Management of Vomiting in Pediatric Patients
For children with vomiting, oral rehydration therapy (ORS) using small, frequent volumes (5 mL every minute) is the first-line treatment, with simultaneous correction of dehydration often reducing vomiting frequency. 1, 2
Initial Assessment
Immediately evaluate for life-threatening conditions and assess hydration status by examining:
- Red flag signs requiring urgent intervention: bilious or bloody vomiting, altered mental status, severe dehydration, toxic/septic appearance, inconsolable crying, or bent-over posture 3
- Skin turgor, mucous membrane moisture, mental status, pulse, capillary refill, and urine output 2, 4
- Degree of dehydration: mild (3-5% fluid deficit), moderate (6-9% fluid deficit), or severe (≥10% fluid deficit) 2, 4
If bilious vomiting is present, immediately stop oral intake and place a nasogastric tube for gastric decompression while evaluating for surgical causes such as malrotation with volvulus or intestinal obstruction. 3
Oral Rehydration Technique for Vomiting Children
The key to successful oral rehydration in vomiting children is administering small volumes frequently rather than allowing ad libitum drinking: 1, 4
- Start with 5 mL of ORS every 1-2 minutes using a spoon or syringe under close supervision 1
- Gradually increase the amount as tolerated 1
- Over 90% of vomiting children can be successfully rehydrated orally using this technique 4
- For intractable vomiting despite small-volume technique, consider continuous nasogastric ORS infusion 1, 4
Common pitfall: Allowing a thirsty child to drink large volumes rapidly from a cup or bottle will perpetuate vomiting and lead to oral rehydration failure. 1
Rehydration Volumes
Based on dehydration severity:
- Mild dehydration (3-5%): 50 mL/kg ORS over 2-4 hours 2, 4
- Moderate dehydration (6-9%): 100 mL/kg ORS over 2-4 hours 2, 4
- Ongoing losses: Replace each vomiting episode with 2 mL/kg ORS 2, 4
Antiemetic Use
Ondansetron may be considered for children over 4 years old when vomiting is severe enough to prevent oral rehydration: 2
- Dose: 0.15 mg/kg IV (maximum 4 mg) or 0.2 mg/kg oral (maximum 4 mg) 5, 3
- Indications: Persistent vomiting preventing oral intake, post-operative vomiting, chemotherapy-induced vomiting, cyclic vomiting syndrome 3
- The FDA label notes safety and effectiveness are established in pediatric patients 4 years and older for chemotherapy-induced nausea/vomiting 5
Important caveat: While ondansetron can facilitate oral rehydration, the primary strategy remains small-volume frequent ORS administration, as this succeeds in over 90% of cases without medication. 1, 4
Dietary Management
- Breastfed infants: Continue nursing on demand throughout the illness 2, 4
- Bottle-fed infants: Resume full-strength formula immediately after rehydration 2, 4
- Older children: Resume normal age-appropriate diet immediately after rehydration or during the rehydration process 2, 6
- Do not withhold food once rehydration is achieved 2
Medications to Avoid
Antimotility drugs (loperamide) should never be given to children under 18 years with acute diarrhea due to risks of toxic megacolon and serious cardiac adverse events. 2, 6
Indications for IV Rehydration
Children requiring IV fluids rather than oral rehydration include those with: 1, 3
- Severe dehydration or shock
- Altered mental status preventing safe oral intake
- Intestinal ileus (absent bowel sounds)
- True intractable vomiting despite proper small-volume ORS technique
- Large urinary ketones combined with altered mental status (these predict IV rehydration need) 7
A serum bicarbonate ≤13 mEq/L predicts failure of oral rehydration after rapid IV correction and typically requires hospital admission for continued IV therapy. 8
When to Seek Immediate Medical Attention
Instruct parents to return or call if the child develops: 1, 2
- Inability to tolerate any oral fluids
- Decreased urine output
- Increased lethargy or irritability
- Persistent or worsening vomiting
- Bloody vomit or stool
- High fever
Children with ≥10 vomiting episodes in the 24 hours before presentation or persistent tachycardia at discharge are at higher risk for return visits and warrant closer follow-up. 7